Company & Sponsor Intelligence

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed0

Countries1

Therapeutic footprint

depressionparkinsons

Indexed studies

NCT06131255DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
depression · ItalyUNKNOWN

NCT01824121Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism
parkinsons · ItalyPHASE1, PHASE2

NCT06167590Integrins and Protocadherins in Glutamatergic Circuits: Identification of Common Signaling Pathways and Molecular Targets in Anxiety and Major Depressive Disorders (GAPsy)
depression · ItalyNA

Intelligence layer updated: 2026-10-15 06:14:04.252491+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →